Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Arginase in glomerulonephritis.

Simon N Waddington1

  • 1Gene Therapy Group, Section of Cell and Molecular Biology, Faculty of Medicine, Imperial College School of Science Technology and Medicine, Sir Alexander Fleming Building, Imperial College Road, London, England SW7 2AZ, UK. s.waddington@ic.ac.uk

Kidney International
|February 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy analysis of in vivo lentiviral gene therapy in pre-clinical ARC syndrome models.

Nature communications·2026
Same author

AAV9-mediated targeting of natural antisense transcript as a novel treatment for Dravet syndrome.

Molecular therapy. Nucleic acids·2026
Same author

Contaminating plasmid sequences and disrupted vector genomes in the liver following adeno-associated virus gene therapy.

Nature medicine·2026
Same author

Genetic therapies for neurological diseases.

Pharmacological reviews·2025
Same author

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice.

Journal of visualized experiments : JoVE·2025
Same author

Ascending Vaginal Infection in Mice Induces Preterm Birth and Neonatal Morbidity.

The American journal of pathology·2025
Same journal

Beyond galactose deficiency: redefining pathogenic IgA in IgA nephropathy.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-storing histiocytosis causing severe acute kidney injury.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
See all related articles

l-Arginine metabolism involves nitric oxide synthase (NOS) and arginase pathways. Increased activity of both enzymes is linked to inflammation, particularly in kidney diseases like glomerulonephritis.

Area of Science:

  • Biochemistry
  • Immunology
  • Nephrology

Background:

  • l-Arginine is metabolized by nitric oxide synthase (NOS) to nitric oxide and citrulline, and by arginase to ornithine and urea.
  • Both NOS and arginase play critical roles in inflammatory processes.
  • Recent research highlights the interaction between arginase isoforms (Arginase I and II) and NOS isoforms (especially NOS II) in pathological conditions.

Purpose of the Study:

  • To review the relationship between arginase isoforms and the inflammation-associated NOS II.
  • To consolidate current understanding of arginase and associated metabolic pathways in inflammation.
  • To identify overlooked aspects in the study of arginase and NOS in pathological situations.

Main Methods:

  • Literature review focusing on studies investigating arginase and NOS activity in inflammatory conditions.

Related Experiment Videos

  • Analysis of the interaction between arginase isoforms (Arginase I, Arginase II) and NOS isoforms (NOS I, II, III).
  • Examination of metabolic pathways involving l-arginine, nitric oxide, and urea cycle enzymes.

    • Main Results:

    • A significant increase in publications discussing both nitric oxide and arginase over the past five years.
    • Strong association between inflammation and high arginase and NOS activity, exemplified by glomerulonephritis.
    • Substantial evidence for interactions between arginase isoforms and NOS isoforms in pathological contexts.

    Conclusions:

    • Arginase is a pathologically significant enzyme with complex interactions with NOS, particularly NOS II, in inflammatory diseases.
    • Understanding the interplay between arginase and NOS metabolism is crucial for interpreting their roles in inflammation.
    • Further research is needed to address overlooked issues in the study of these enzymes in disease.